Ignite Creation Date:
2024-05-05 @ 12:03 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00227773
Status:
WITHDRAWN
Last Update Posted:
2015-10-08
First Post:
2005-09-26
Brief Title:
Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors
Sponsor:
Eastern Cooperative Oncology Group
Organization:
Eastern Cooperative Oncology Group
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Islet Cell Carcinoma |
| Gastrointestinal Carcinoid Tumor |
Keywords:
| Name | View |
|---|---|
| somatostatinoma | View |
| localized gastrointestinal carcinoid tumor | View |
| metastatic gastrointestinal carcinoid tumor | View |
| recurrent gastrointestinal carcinoid tumor | View |
| regional gastrointestinal carcinoid tumor | View |
| recurrent islet cell carcinoma | View |
| gastrinoma | View |
| insulinoma | View |
| WDHA syndrome | View |
| glucagonoma | View |
| pancreatic polypeptide tumor | View |